Clinical Trials Browser

Phase 2 × Colorectal Neoplasms × Methods × Clear all

NCT01057017 2020-02-17

First-Line FOLFOX-Bevacizumab for Advanced Colorectal Cancer With Wild-Type Ras

Phase 2 Terminated

5 enrolled 7 charts

Gastrointestinal

Colorectal Neoplasms